We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+23.45%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$208M
AUM Growth
+$24.2M
Cap. Flow
+$3.02M
Cap. Flow %
1.45%
Top 10 Hldgs %
36.52%
Holding
103
New
33
Increased
10
Reduced
10
Closed
44

Top Buys

1
WMGI
Wright Medical Group Inc
WMGI
+$6.88M
2
GILD icon
Gilead Sciences
GILD
+$6.72M
3
PBYI icon
Puma Biotechnology
PBYI
+$5.55M
4
CPHD
Cepheid Inc
CPHD
+$5.06M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$4.64M

Top Sells

1
CYH icon
Community Health Systems
CYH
+$5.48M
2
TRNX
TORNIER N V SHARES (NLD)
TRNX
+$4.78M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$4.49M
4
AGN
Allergan Inc
AGN
+$4.46M
5
HCA icon
HCA Healthcare
HCA
+$4.23M

Sector Composition

1 Healthcare 69%
2 Technology 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRMR icon
76
Larimar Therapeutics
LRMR
$384M
– –
-6,250
Closed -$1.47M
MDT icon
77
Medtronic
MDT
$106B
– –
-30,000
Closed -$1.86M
NBIX icon
78
CALL
Neurocrine Biosciences
NBIX
$17.2B
– –
-200,000
Closed -$3.13M
NBIX icon
79
Neurocrine Biosciences
NBIX
$17.2B
– –
-100,000
Closed -$1.57M
VNDA icon
80
CALL
Vanda Pharmaceuticals
VNDA
$327M
– –
-100,000
Closed -$1.04M
VRTX icon
81
Vertex Pharmaceuticals
VRTX
$123B
– –
-40,000
Closed -$4.49M
CMRX
82
DELISTED
Chimerix, Inc.
CMRX
– –
-80,500
Closed -$2.22M
ALIM
83
PUT
DELISTED
Alimera Sciences
ALIM
– –
-13,333
Closed -$1.08M
CNCE
84
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-280,966
Closed -$3.54M
CLVS
85
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-65,000
Closed -$2.95M
ATRS
86
DELISTED
Antares Pharma, Inc.
ATRS
– –
-1,100,000
Closed -$2.01M
FLXN
87
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-12,488
Closed -$228K
GWPH
88
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-35,000
Closed -$2.83M
MNK
89
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-45,000
Closed -$4.06M
EVHC
90
DELISTED
Envision Healthcare Holdings Inc
EVHC
– –
-33,400
Closed -$3.47M
CASC
91
DELISTED
Cascadian Therapeutics, Inc.
CASC
– –
-116,667
Closed -$1.34M
SPNC
92
DELISTED
Spectranetics Corp
SPNC
– –
-100,000
Closed -$2.66M
AEGR
93
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-60,000
Closed -$2M
CPHD
94
CALL
DELISTED
Cepheid Inc
CPHD
– –
-100,000
Closed -$4.4M
UNIS
95
DELISTED
Unilife Corporation
UNIS
– –
-15,000
Closed -$344K
ZSPH
96
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
– –
-85,000
Closed -$3.33M
CYBX
97
DELISTED
CYBERONICS INC
CYBX
– –
-75,000
Closed -$3.84M
THOR
98
DELISTED
THORATEC CORPORATION
THOR
– –
-140,000
Closed -$3.74M
TRNX
99
DELISTED
TORNIER N V SHARES (NLD)
TRNX
– –
-200,000
Closed -$4.78M
RCPT
100
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
– –
-12,300
Closed -$764K
1 2 3
4
5

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q4 2014 Portfolio in Review

As of Q4 2014, Ghost Tree Capital held 103 positions worth $208M, up 13% from $184M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Ghost Tree Capital's Q4 2014 filing shows 33 new, 10 increased, 10 reduced and 44 closed positions. Its largest new stake was Wright Medical Group Inc: 235,000 shares worth $6.31M. The largest sale was Community Health Systems, an estimated $5.48M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 63% a quarter earlier, followed by Technology.

  • Ghost Tree Capital's largest Q4 2014 buy was Wright Medical Group Inc: 235,000 shares worth $6.31M.
  • Ghost Tree Capital added most to Puma Biotechnology in Q4 2014, an estimated $5.55M increase.
  • Ghost Tree Capital's biggest Q4 2014 reduction was AtriCure, cutting an estimated $2.57M.
  • Ghost Tree Capital fully exited Community Health Systems in Q4 2014, selling an estimated $5.48M.
  • Ghost Tree Capital's ten largest holdings make up 37% of its $208M portfolio in Q4 2014.
  • Ghost Tree Capital opened 33 new positions and closed 44 in Q4 2014.
  • Ghost Tree Capital's portfolio value rose 13% quarter-over-quarter to $208M.

Based on Ghost Tree Capital's 13F filing for Q4 2014, filed 17 Feb 2015.